Analyst Ratings for Aeglea Biotherapeutics (AGLE)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/25/2023 | Stifel » Updated 10/23/2023 |
Alex Thompson | New Coverage | Buy (N/A) |
23.00 (N/A) |
0.59 (12.01) |
1935.59% | Details |
| 4/12/2023 | Wells Fargo » Updated 11/13/2023 |
Yanan Zhu | Downgrade | Equal Weight (Overweight) |
12.00 (13.00) |
0.26 (12.01) |
4519.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
